четверг, 16 июня 2016 г.

Better Buy: Johnson & Johnson vs. Eli Lilly

Better Buy: Johnson & Johnson vs. Eli Lilly


Pharmaceutical stocks have been hammered over the past year, leaving potential buyers with a plethora of potential bargains. At Johnson & Johnson , pharmaceutical sales have taken off, but consumer goods and medical devices still comprise the majority of its total revenue.



from Biotech News